Market Overview - The market showed strong fluctuations throughout the day, with all three major indices rising over 1%, and the Shanghai Composite Index achieving a 17-day consecutive rise [1] - AI application sectors experienced a significant surge, with stocks like BlueFocus and Hand Information hitting the daily limit [1] - The commercial aerospace concept continued its strong performance, with China Satellite and China Satcom both reaching new highs [1] - The brain-computer interface concept was also active, with stocks like DaoTech and Yanshan Technology hitting the daily limit [1] - Over 4,100 stocks in the Shanghai, Shenzhen, and Beijing markets rose, with a total transaction volume of 3.64 trillion, setting a new record for daily trading in A-shares [1] AI Marketing - The AI marketing concept saw a wave of limit-up stocks, including Gravity Media, Leo Holdings, and BoRui Communication [4] - Elon Musk announced on social media that he would open-source the latest content recommendation algorithm for the X platform within a week, interpreted by the market as his entry into the GEO space [4] - DeepSeek is set to release its next-generation flagship AI model, DeepSeek V4, in February, which reportedly outperforms major models like Anthropic Claude and OpenAI GPT series in programming capabilities [4][7] - Anthropic's Claude Code received a significant update, marking a new phase in global AI programming competition [4] Aerospace Sector - The aerospace sector continued to rise, with stocks like Luxin Investment, Goldwind Technology, and Daye Shares hitting the daily limit [10] - China applied for frequency resources for over 200,000 satellites, indicating a strategic national-level initiative [11] - Experts believe that the establishment of the Radio Innovation Institute will accelerate the 6G process, integrating satellite networks with ground communication networks [14] AI Medical - The AI medical sector also performed well, with companies like Meinian Health and Dean Diagnostics seeing consecutive gains [15] - OpenAI launched "ChatGPT Health," a health-related dialogue space that connects electronic medical records and health applications [15] - The demand for AI in healthcare is expected to grow significantly, driven by an aging population and an increase in chronic disease patients [18]

Market Performance - The medical device sector increased by 1.89% on January 12, with Kangzhong Medical leading the gains [1] - The Shanghai Composite Index closed at 4165.29, up 1.09%, while the Shenzhen Component Index closed at 14366.91, up 1.75% [1] Top Gainers - Kangzhong Medical (688607) closed at 53.99, up 20.00% with a trading volume of 154,300 shares and a transaction value of 817 million [1] - Laijing Co. (301093) closed at 57.68, up 19.99% with a trading volume of 139,400 shares and a transaction value of 753 million [1] - Baolait (300246) closed at 10.91, up 17.19% with a trading volume of 499,500 shares and a transaction value of 523 million [1] Top Losers - Rejing Bio (688068) closed at 188.88, down 8.29% with a trading volume of 26,300 shares and a transaction value of 509 million [2] - Wuzhou Medical (301234) closed at 44.06, down 7.53% with a trading volume of 42,900 shares and a transaction value of 192 million [2] - New Industry (300832) closed at 60.41, down 3.84% with a trading volume of 53,700 shares and a transaction value of 327 million [2] Fund Flow Analysis - The medical device sector saw a net inflow of 199 million from institutional investors, while retail investors experienced a net inflow of 41.84 million [2] - Retail funds showed a net outflow of 241 million, indicating a shift in investment behavior [2] Individual Stock Fund Flow - Lepu Medical (300003) had a net inflow of 167 million from institutional investors, representing 5.74% of total trading [3] - Yuyue Medical (002223) experienced a net inflow of 156 million from institutional investors, with a net outflow of 74.75 million from retail investors [3] - Union Medical (688271) saw a net inflow of 104 million from institutional investors, while retail investors had a net outflow of 53.01 million [3]

融资融券数据显示，该股最新（1月9日）两融余额为2.93亿元，其中，融资余额为2.93亿元，较上一个 交易日增加1558.54万元，增幅为5.62%；近10日两融余额合计增加2007.81万元，增幅为7.36%，其间融 资余额增长7.36%。（数据宝） 1月12日盘中科创板股康众医疗涨停，截至09:40，股价报53.99元，成交2.81亿元，换手率6.06%，振幅 8.76%。 科创板个股中，截至发稿上涨的共有270只，涨幅在10%以上的共有12只，除康众医疗之外，涨停的还 有信科移动-U、通源环境等，下跌的有322只，跌幅较大的有仕佳光子、九联科技、强一股份，分别下 跌5.48%、5.48%、5.44%。 资金面上，康众医疗上一交易日主力资金净流入2017.18万元，近5日净流入448.17万元。 （文章来源：证券时报网） ...

Core Viewpoint - On December 29, a block trade of Jiangsu Kangzhong Digital Medical Technology Co., Ltd. occurred, with a transaction volume of 265,500 shares and a transaction amount of 10.9997 million yuan, reflecting a discount of 9.54% compared to the closing price of the day [2] Group 1: Trading Details - The block trade price was 41.43 yuan per share, while the closing price for the day was 45.80 yuan, which represents a 7.23% increase [2] - The buyer was Guangdong Kai Securities Co., Ltd. Shenzhen Shennan Avenue Securities Business Department, and the seller was Western Securities Co., Ltd. Hubei Branch [2] Group 2: Stock Performance - The stock had a turnover rate of 4.57% for the day, with a total transaction amount of 180 million yuan and a net inflow of main funds amounting to 1.4707 million yuan [2] - Over the past five days, the stock has increased by 6.51%, with a total net outflow of funds amounting to 6.3093 million yuan [2] Group 3: Margin Data - The latest margin financing balance for the stock is 278 million yuan, which has increased by 15.2825 million yuan over the past five days, reflecting a growth rate of 5.81% [2] Group 4: Company Information - Jiangsu Kangzhong Digital Medical Technology Co., Ltd. was established on May 23, 2007, with a registered capital of 88.129027 million yuan [2]

中信证券股份有限公司 关于江苏康众数字医疗科技股份有限公司 首次公开发行股票募集资金投资项目结项并将节余募集资金永久补 充流动资金及投入研发项目的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐人"）为江苏康众数字医疗 科技股份有限公司（以下简称"公司"、"康众医疗"）首次公开发行股票并上市的保荐 人。根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板股票上市规则》《科 创板上市公司持续监管办法（试行）》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》《上市公司募集资金监管规则》等有关规定，对康众医疗首次公开发行 股票募集资金投资项目结项并将节余募集资金永久补充流动资金及投入研发项目进行了 审慎核查，核查情况及核查意见如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意江苏康众数字医疗科技股份有限公司首次公 开发行股票注册的批复》（证监许可〔2020〕3662 号）同意注册，公司向社会公开发行 人民币普通股 22,032,257 股，每股发行价为人民币 23.21 元，合计募集资金人民币 511,368,684.97 元，扣除各项发行费用（不含税）人民币 64 ...

证券代码：688607 证券简称：康众医疗 公告编号：2025-049 江苏康众数字医疗科技股份有限公司 关于首次公开发行股票募集资金投资项目结项并将节 余募集资金永久补充流动资金及投入研发项目的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次结项的募投项目名称：平板探测器生产基地建设项目、研发服务中 心建设项目。 本次节余募集资金金额合计为 7,364.95 万元（不含期间利息及理财收 益），募集资金使用金额中含待支付尾款 3,514.85 万元，公司拟将上述节余募 集资金 3,000.00 万元投入"新一代平板探测器设计与制造技术"研发项目、 4,364.95 万元永久补充流动资金。 | 结项名称 | 募集资金承诺使 | 募集资金实际使 | 待支付尾款金额 | 预计节余募集资金金 | | --- | --- | --- | --- | --- | | | 用金额（A） | 用金额（B） | （C） | 额（D）D=A-B-C | | 平板探测器 | | | | | | 生产基地建 | 21,386 ...

Core Viewpoint - Kangzhong Medical (688607.SH) has announced the conclusion of its fundraising projects and the allocation of surplus funds for operational and R&D purposes [1] Group 1: Fundraising Projects - The company held its 13th (temporary) meeting of the third board on December 29, 2025, to review and approve the conclusion of its initial public offering fundraising projects [1] - The projects concluded include the "Flat Panel Detector Production Base Construction Project" and the "R&D Service Center Construction Project" [1] Group 2: Surplus Fund Allocation - The total amount of surplus fundraising is 73.6495 million yuan (excluding interest and financial income) [1] - Of the total fundraising amount, 35.1485 million yuan is pending payment [1] - The company plans to allocate 30 million yuan to the "Next Generation Flat Panel Detector Design and Manufacturing Technology" R&D project and 43.6495 million yuan to permanently supplement working capital [1]

Market Overview - The medical device sector experienced a decline of 0.74% on December 29, with Huakang Clean leading the drop [1] - The Shanghai Composite Index closed at 3965.28, up 0.04%, while the Shenzhen Component Index closed at 13537.1, down 0.49% [1] Top Performers - Meihao Medical (301363) saw a closing price of 25.04, with an increase of 8.30% and a trading volume of 197,100 shares, totaling a transaction value of 482 million yuan [1] - Mailande (688273) closed at 41.73, up 8.22%, with a trading volume of 55,200 shares and a transaction value of 227 million yuan [1] - Kangzhong Medical (688607) closed at 45.80, up 7.23%, with a trading volume of 40,200 shares and a transaction value of 180 million yuan [1] Underperformers - Huakang Clean (301235) closed at 39.21, down 8.54%, with a trading volume of 123,300 shares and a transaction value of 488 million yuan [2] - C Jianxin (688805) closed at 47.16, down 7.26%, with a trading volume of 89,000 shares and a transaction value of 426 million yuan [2] - Furuim Medical (300049) closed at 71.93, down 4.20%, with a trading volume of 66,800 shares and a transaction value of 485 million yuan [2] Capital Flow - The medical device sector saw a net outflow of 565 million yuan from institutional investors, while retail investors experienced a net inflow of 328 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are more active [2] Individual Stock Capital Flow - Meihao Medical (301363) had a net outflow of 54.30 million yuan from institutional investors, with retail investors also showing a net outflow of 0.76 million yuan [3] - Jigaofazhan (600807) experienced a net inflow of 44.75 million yuan from institutional investors, while retail investors had a net outflow of 61.29 million yuan [3] - Kangzhong Medical (688626) saw a net inflow of 44.26 million yuan from institutional investors, with retail investors showing a slight net outflow [3]

Core Viewpoint - The company is actively focusing on the research and development of new technologies, including AI, and is expanding its product offerings in this area [1] Group 1: Company Initiatives - The company has introduced several products and services related to AI, including intelligent beamers, intelligent DR solutions, and AI-based grassroots medical diagnostics [1]

Group 1 - The medical device sector increased by 0.56% on December 19, with Kangzhong Medical leading the gains [1] - The Shanghai Composite Index closed at 3890.45, up 0.36%, while the Shenzhen Component Index closed at 13140.22, up 0.66% [1] - Notable gainers in the medical device sector included Kangzhong Medical, which rose by 7.36% to a closing price of 44.90, and Rendu Biotech, which increased by 6.78% to 50.40 [1] Group 2 - The medical device sector experienced a net inflow of 3.65 million yuan from institutional investors, while retail investors saw a net inflow of 15 million yuan [2] - Major stocks with significant net inflows included Rejing Bio with 49.71 million yuan and Yuyue Medical with 43.84 million yuan [3] - Conversely, retail investors showed net outflows in several stocks, including Yuyue Medical and Mairui Medical, indicating a mixed sentiment in the market [3]